Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune cell activating receptors" is a categorical term for a diverse group of membrane-spanning or cell-surface proteins found on various immune cells (including T cells, NK cells, macrophages, dendritic cells, and others) that transduce activating signals. These include but are not limited to receptors such as CD28 (and its family), NKG2D, natural cytotoxicity receptors (NCRs like NKp30, NKp44, NKp46), killer cell immunoglobulin-like receptors (KIRs, a subset being activating), Fc receptors (such as FcγRIIA/FCGR2A), and others[2][6][7]. Each receptor has its own ligand specificity, intracellular signaling cascades (often involving tyrosine phosphorylation motifs such as ITAMs), and role in mediating immune effector functions, including cytotoxicity, cytokine secretion, and proliferation. The entry as given is too generic for direct research or therapeutic targeting and should be resolved into specific molecular entities for scientific and drug development contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune cell activating receptors.